MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1253/circj.72.392

Медицинская библиотека · Circulation journal : official journal of the Japanese Circulation Society · 2008

Clinical safety of drug-eluting stents in the Korea acute myocardial infarction registry.

Lee Sang Rok, Jeong Myung Ho, Ahn Young Keun, Chae Shung Chull, Hur Seung Ho, Kim Young Jo, Seong In Whan, Chae Jei Keon, Hong Taek Jong, Rhew Jae Young, Cho Myeong Chan, Bae Jang Ho, Rha Seung Woon, Kim Chong Jin, Jang Yang Soo, Park Seung Jung, Korea Acute Myocardial Infarction Registry Investigators

СтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Percutaneous coronary intervention (PCI) with drug-eluting stents (DES) may be useful in patients with acute myocardial infarction (AMI), but safety issues still need to be solved. This study was undertaken to investigate the incidence of major adverse cardiac events (MACE) and stent thrombosis in DES-implanted AMI patients in real-life clinical practice.

METHODS AND

RESULTS

On-line registry of AMI cases at the web site www.kamir.or.kr has been performed in 41 primary PCI centers in Korea and between November 2005 and September 2006, 1,541 surviving patients who had been implanted with either Cypher or Taxus stents were enrolled for analysis during a 6-month clinical follow-up. There were 2 groups: group I [834 patients, 61.9+/-11.9 years: sirolimus-eluting stent (Cypher)], group II [707 patients, 62.9+/-12.0 years: paclitaxel-eluting stent (Taxus)]. At both 1 and 6 months the incidence of MACE was not significantly different between the 2 groups. There were 17 cases of stent thrombosis, but the incidence of stent thrombosis was not significantly different between the 2 groups (group I:II=9 (1.1%):8 (1.1%), p=1.000). The stent type, length, number, lesion complexity and diabetes were not significant for the incidence of MACE or stent thrombosis after adjustment.

CONCLUSION

MACE and stent thrombosis rates did not differ between 2 types of DES identified in Korea Acute Myocardial Infarction Registry (KAMIR). DES can be used in patients with AMI with a relatively low 6-month MACE rate.

Для цитирования: Lee Sang Rok, Jeong Myung Ho, Ahn Young Keun, Chae Shung Chull, Hur Seung Ho, Kim Young Jo, Seong In Whan, Chae Jei Keon, Hong Taek Jong, Rhew Jae Young, Cho Myeong Chan, Bae Jang Ho, Rha Seung Woon, Kim Chong Jin, Jang Yang Soo, Park Seung Jung, Korea Acute Myocardial Infarction Registry Investigators. Clinical safety of drug-eluting stents in the Korea acute myocardial infarction registry.. Circulation journal : official journal of the Japanese Circulation Society. 2008. DOI: 10.1253/circj.72.392.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.